To investigate the in-vivo precision and clinical feasibility of 3D-QALAS -a novel method for simultaneous three-dimensional myocardial T1-and T2-mapping.
Introduction
Quantification of myocardial relaxation times with cardiovascular magnetic resonance (CMR) provides important information for the non-invasive assessment of myocardial tissue characterization. Diffuse tissue changes have now become possible to assess non-invasively with information from the longitudinal relaxation time (T1) and the transverse relaxation time (T2) by using T1-and T2 mapping methods. Mapping of the longitudinal relaxation time has for example been used in the assessment of acute-and chronic myocardial infarction [1] and in the assessment of diffuse fibrosis in patients with cardiomyopathy [2] . Mapping of the transverse relaxation time can be used in the detection of edematous areas in the myocardium [3] and has for example shown improved detection in patients with acute inflammatory cardiomyopathy [4] . Especially for investigating diffuse tissue changes a good 3D coverage of the complete LV is preferred.
Various methods for myocardial relaxation times mapping are available today that typically provide one 2D slice of the heart with pixel-wise information about either longitudinal T1 relaxation time or transverse T2 relaxation time in one breath hold [5] [6] [7] [8] [9] . Coverage of the complete LV using these techniques is time consuming, and the large number of breath-holds can be exhaustive to the patient. Some three-dimensional mapping methods for either T1 or T2 quantification do exist, which often are free-breathing or navigator based methods [10] [11] [12] . Mapping methods providing simultaneously quantification of both T1 and T2 are few but there are some 2D methods, for example by Blume et al [13] and Akçakaya et al [14] . While several three-dimensional (3D) methods for simultaneous T1 and T2 quantification exist for non-cardiac applications [15] [16] [17] , so far only one 3D method for cardiac application has been proposed; 3D-QALAS (3D-quantification using an interleaved Look-Locker acquisition sequence with T2 preparation pulse) [18] . Extending upon the recently published consensus document for myocardial T1 mapping [19] , which recommends that T1 quantification is performed on a global or segmental basis, the 3D-QALAS method aims to precisely perform relaxation times mapping of T1 and T2 in all 16 segments of the left ventricular myocardium in a single breath-hold only.
The 3D-QALAS method is based on a cardiac triggered 3D spoiled Turbo Field Echo sequence using inversion recovery with an interleaved T2 preparation pulse. The estimation of the relaxation times is based on a simulation of the magnetization vector over the acquisition scheme using an iterative analysis approach, instead of using a conventional curve-fitting algorithm as commonly used in the 2D mapping techniques. The ability to perform 3D T1-/T2-mapping in a single breath hold is advantageous to both 2D mapping and 3D-navigator based mapping with respect to number of breath holds and total acquisition time, which is of importance for the clinical feasibility of a method.
According to the consensus statement for myocardial T1 mapping, accuracy and precision of new pulse sequences should be tested systematically. Several of the existing 2D mapping methods have been validated separately as well as against each other with respect to accuracy and precision [20] [21] [22] . Measurements have been performed both in-vivo and in-vitro to estimate the advantages and limitations of the different methods. Validation of the 3D-QALAS method has been performed invitro using simulated arrhythmia, various flip angles and a wide range of heart rates. The results showed no effect of these parameters within a clinically relevant range and the method revealed a very good correlation against relaxation times measurements with reference methods, Inversion Recovery for T1 measurement and Multi Echo for T2 measurement. The combined three-dimensional T1-and T2-mapping method was also tested in-vivo in 10 healthy volunteers with very good correlation to existing in-vivo 2D mapping methods [18] . These results about the accuracy of T1-and T2-mapping using 3D-QALAS are promising, but for clinical practice and longitudinal follow of patients good robustness and precision of the measurements are also crucial. The usability of quantitative methods is thus dependent on a good precision. Another important factor for the clinical feasibility of the method is the ability to measure not only native T1 and T2, but also postcontrast T1. Finally, the technique should be feasible in patients, for which longer breath holds can be challenging. As the T1 mapping consensus document [19] recommends that T1 quantification is performed on a global or segmental basis, precision and clinical feasibility should also be investigated on a global or segmental basis.
The aim of this study was to investigate the in-vivo precision and clinical feasibility of 3D-QALAS. The precision of the method was investigated through the assessment of native T1 and T2 repeatability of independent scans, dependent scans and consecutive scans in healthy volunteers. Clinical feasibility was investigated through the assessment of native T1 and T2 together with post-contrast T1 in patients with different cardiac pathologies using 3D-QALAS, MOLLI and T2-GraSE.
Materials and methods
All subjects gave written informed consent to participate in the study and approval was granted from the Regional Ethical Review Board in Linköping.
Study populations and CMR protocols
The study population consisted of ten healthy volunteers and 23 patients. The ten healthy volunteers had no history of cardiovascular disease and underwent four scan blocks during the same day, see table 1. Table 1 . CMR protocols overview of the four scans performed on the healthy subjects. The subject was removed from the bore and repositioned between the first and the second scan block to achieve independent measurements and thus investigate repeatability of the method, which is a measure of precision under repeatability conditions according to ISO [23] . The scan protocol for the first, second and third scan blocks consist of three MOLLI acquisitions (apical, mid-ventricular and basal), three T2-GraSE acquisitions (apical, mid-ventricular and basal) and one 3D-QALAS acquisition. The scan protocol for the fourth scan block consists of eight mid-ventricular MOLLI acquisitions, eight mid-ventricular T2-GraSE acquisitions and eight 3D-QALAS acquisitions with the aim to investigate precision by using standard deviations of repeated measurements.
Mapping method
A total of 23 patients with clinically significant aortic stenosis (5 patients of which 2 women, average age 66 years), ischemic cardiomyopathy (8 patients of which 3
women, average age 72 years), idiopathic dilated cardiomyopathy (7 patients of which 2 women, average age 65 years) or diastolic heart failure (3 patients of which 3 women, average age 79 years) were consecutively included in the study. The patients underwent a MR scanning protocol including injection of 0.2 ml/kg Gadovist-contrast agent. Pre-contrast acquisition included one 3D-QALAS, one midventricular MOLLI and one mid-ventricular T2-GraSE acquisition. Post contrast, one 3D-QALAS and one mid-ventricular MOLLI acquisition were performed.
MR sequence parameters
All CMR scans were performed using a 3T system, Philips Ingenia (Best, The Netherlands). The T2-GraSE acquisition had the same resolution as the MOLLI acquisition and was performed during a breath hold of 15 heartbeats. Nine different echo times, range between 9 ms and 84 ms, were used for the calculation of the T2-map and the repetition time was 1000 ms.
Image analysis
Generation of the 3D-QALAS T1-and T2-maps was performed on a standalone version of SyMRI (SyntheticMR, Sweden). 3D-QALAS provides 5 data points for each voxel, 1 after a T2prep pulse and 4 after an inversion pulse, all acquired at late diastole [18] . An iterative approach was applied to calculate the steady-state magnetization vector under the influence of the T2prep pulse, the inversion pulse, the continuous RF excitation and spoiling during the acquisition together with the delay times in between the acquisitions. Iterations were driven by a cost-function to minimize the difference between the simulated magnetization vector and the measured signal intensity of the 5 data points. T1-and T2-maps from the reference methods were generated directly on the MRI scanner console. The generated T1-and T2-maps from all methods were analyzed using Segment v 1.9 R3644
(http://segment.heiberg.se) [24] . For the three first scans of the healthy volunteers, myocardial data were manually contoured with respect to epi-and endo-cardial borders. Based on these manual contours, 17-segment bull's eye plots were created automatically by the analysis software. For the fourth scan, only mid-ventricular data were acquired for the references and they were thus only analyzed as six midventricular segments, according to the 17-segment model recommended by the American Heart Association (AHA) [25] . Since the 3D-QALAS acquisition from the fourth scan provides 13 slices, a bull's eye plot was created as a first step but for comparison with the reference methods only the data from the six mid-ventricular segments of the bull's eye plot were included in the results.
Patient data were also contoured and analyzed in Segment. The mid-ventricular data from the reference methods were analyzed as six segments. 3D-QALAS patient data were analyzed as a bull's eye plot but for comparison with reference methods, only data from the six mid-ventricular segments were included.
Unless otherwise stated, myocardial T1-and T2 relaxation times data were presented globally as an average over the slice/slices.
Statistical analysis
For 3D-QALAS, MOLLI and T2 GraSE, relaxation times measurement variations between the three first scans were calculated as mean difference between scans and the corresponding 95 % confidence interval. Variations between the first and second scan illustrate precision under repeatability conditions and variations between the second and third scan illustrate precision under intra-scan conditions. The agreement between separate measurements, assessment of repeatability, was determined by using the Pearson correlation analysis for scan 1 versus scan 2 and scan 2 versus scan 3 in the healthy volunteers.
The eight repeated examinations from scan block four were analyzed by using intrascan standard deviation. Paired t-tests were conducted to examine whether there are significant differences between the eight acquisitions in their sequential order.
Mean value and standard deviation were calculated for the subjects. An intraclass correlation analysis using a two-way random model was performed on the data from the fourth scan to get a measure of how strongly subjects in the same group 
Results
Ten healthy volunteers and 23 patients with different cardiac pathologies were included in this study. A characteristics summary of the subjects can be seen in 
Healthy volunteers
All data were successfully acquired for the healthy volunteers.
Myocardial relaxation times from the two independent scans, first scan versus the second scan, showed a less good correlation than myocardial relaxation times from the second scan versus the third scan, for both 3D-QALAS and the reference methods. The correlation coefficients are presented in table 3 together with the average difference and 95 % confidence interval (CI) between the three different scans, where the largest 95 % CI of the difference is found between the first two independent scans. Average relaxation time value and standard deviation of all ten subjects, i.e. on a group level, for the four scans are illustrated in figure 1 for T1 and figure 2 for T2 (scan four is illustrated as the eight separate acquisitions, denoted as SD1 -SD8).
Results from the fourth scan are presented as average value and standard deviation over the eight repeated acquisitions for each healthy volunteer, i.e. results on an individual level, ( figure 3 and 4) . The overall average myocardial relaxation time value and standard deviation from eight repeated acquisitions within the population group of healthy subject with 3D-QALAS is 1178 ± 18.5 ms (1.6%) for T1 measurements and 52.7 ± 1.2 ms (2.3%) for T2 measurements. 
Discussion
This study investigated the precision of simultaneous native T1 and T2 mapping using 3D-QALAS in healthy volunteers and the feasibility of the method for T1 and T2 quantification of native and post contrast myocardium in patients. Precision has been investigated between two independent scans, between two dependent scans and as standard deviation of eight consecutive scans in ten healthy volunteers. All methods (MOLLI, GraSE and 3D-QALAS) showed good precision. The standard deviation of eight consecutive scans was slightly better using MOLLI for T1 and GraSE for T2 than for 3D-QALAS, while the correlation for two independent scans was slightly better using 3D-QALAS. Myocardial T1 and T2 relaxation times obtained with 3D-QALAS correlated very well with reference methods, MOLLI and GraSE, in the 23 included patients for both native as well as post contrast myocardial tissue.
Eight repeated measurements were performed to estimate precision through intrascan standard deviation of dependent acquisitions. The overall average standard deviations were slightly larger with 3D-QALAS for both T1-and T2 measurements than with the reference methods, MOLLI for T1-and GraSE for T2 measurements.
The intra-scan standard deviation from eight acquisitions was 1.6 % with 3D-QALAS T1, 0.9 % with MOLLI, 2.3 % with 3D-QALAS T2 and 1.6 % with GraSE.
Relaxation times values representing healthy myocardial tissue are well-known to differ depending on for example vendor and mapping method used, which is a problem when comparing values with each other [20] , as in this study where myocardial relaxation times for the consecutive scans estimated with the 3D-QALAS method are slightly longer than with the reference methods. Using intraclass correlation analysis, individual differences of the methods could be taken into account by separating the subjects from each other in the analysis. Intraclass correlation analysis of the eight scans indicated very good repeatability of 3D-QALAS for T1 and T2 mapping, and even better for MOLLI and T2-GraSE.
However, the larger 95 % confidence interval between the independent than between the dependent scans of all methods indicates that the precision cannot be completely assessed by the consecutive scans. For example the positioning of the patient, positioning of the shim-box and the exact slice positioning are factors that seem to influence the outcome of myocardial relaxation times mapping for both the 3D-QALAS method and for the reference methods. The evaluation using independent scans is therefore of major importance, as it best reflects the expected precision in healthy subjects as well as in patients. 3D-QALAS showed a very good correlation between both the independent scans, scan block 1 and scan block 2, and the dependent scans, scan block 2 and scan block 3. This indicates that 3D-QALAS is a robust method even when effects connected to independent scan situations arise. The robustness of the method, even between independent scans, might be due to the fact that 3D-QALAS excites a 3D slab instead of just a 2D slab that reduces the influence of slice positioning effects. In addition, the iterative analysis approach handles several possibly confounding factors that could affect the estimate of T1 and T2 relaxation times, such as the T2 dependency and the influence of heart rate, making the 3D-QALAS method more stable than methods using conventional curve-fitting approach.
The native T1 times for healthy subjects presented in this study, both with MOLLI and 3D-QALAS, are in the upper part of the normal range reported in earlier studies [26] and also compared to earlier in-vivo results with 3D-QALAS [18] .
Healthy myocardial T1 relaxation times seems to differ fairly much between individuals, meaning that the inter subject variability is larger than the intra subject variability. Ten healthy subjects are not sufficient to establish a range of normal/healthy myocardial T1 or T2 relaxation times, which also isn't the objective of this study. To obtain reference values of normal/healthy myocardial T1 or T2 relaxation times, the study population has to be substantially expanded and a multi-center study might be of interest.
As described in earlier work [18] , performing relaxation times mapping in a whole 3D-volume instead of in a 2D slice, requires sampling of larger quantities of data.
To be able to sample the larger amount of data without losing valuable information, such as the important in-plane resolution or veracity in the relaxation time measurement, some other considerations has to be made regarding for example a slightly longer acquisition window, <230 ms, and a larger slice thickness, 12 mm, than the conventional 2D mapping methods. These compromises have to be compared to the advantage of getting 3D data from both T1 and T2 in one breath hold.
The standard deviations presented for the patient data in this study are much larger than for the healthy population data, which is reasonable since the patients suffer from different cardiac pathologies that are well known to affect the myocardial relaxation times. Moreover, the standard deviation for patients are based on relaxation times from 23 different subjects and one measurement per subject and method while the standard deviations presented for healthy volunteers are based on 8 consecutive measurements within the same subject and should thus not be compared.
A very good correlation is also seen between the 3D-QALAS method and the reference methods for patients with different cardiac pathologies. These patients were investigated with the same 3D-QALAS scan before and after injection of gadolinium based contrast agent ( figure 7 and 8 The 3D-QALAS sequence has in this study shown applicability and robustness and provides reliable relaxation time mapping results for both T1 and T2.
Limitations
Increasing the number of independent scans in the study would be desirable to achieve an even more accurate measure of precision, but since it is demanding for the subject (this experimental setup provided in average 62 breath holds per subject) and also an extremely time consuming procedure to perform independent scans, the number of scans were limited. Other limitations are the small number of subjects included in the study and the large age range of the subjects. Since the study included in-vivo examinations, no specific heart rate was used and heart rate dependency of a mapping method might therefore influence the outcome. Only midventricular data from the reference methods were used in the repeated consecutive scans, while 3D-QALAS included data from several slices to create comparative mid-ventricular data in the analysis program.
Conclusions
The results from this study indicate that 3D T1 and T2 mapping in the left ventricle is feasible in one breath hold for patients with different cardiac pathologies. 
